Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBH NYSEARCA:PBE NYSEARCA:PJP NYSEARCA:XPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBHVanEck Biotech ETF$204.14-0.7%$191.63$154.75▼$212.54$400.10M0.695,145 shs3,217 shsPBEInvesco Biotechnology & Genome ETF$90.56-0.7%$85.18$63.92▼$94.06$282.55M0.77,020 shs2,805 shsPJPInvesco Pharmaceuticals ETF$117.60-0.8%$112.04$80.63▼$122.69$353.98M0.4534,423 shs424,578 shsXPHSPDR S&P Pharmaceuticals ETF$66.82-2.4%$61.03$40.80▼$70.15$451.04M0.5887,164 shs111,836 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBHVanEck Biotech ETF-0.69%-2.94%+8.84%+5.31%+29.02%PBEInvesco Biotechnology & Genome ETF-0.67%-1.52%+7.68%+11.27%+36.92%PJPInvesco Pharmaceuticals ETF-0.80%-2.07%+3.29%+10.56%+42.58%XPHSPDR S&P Pharmaceuticals ETF-2.37%-0.68%+10.87%+16.68%+58.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBHVanEck Biotech ETF$204.14-0.7%$191.63$154.75▼$212.54$400.10M0.695,145 shs3,217 shsPBEInvesco Biotechnology & Genome ETF$90.56-0.7%$85.18$63.92▼$94.06$282.55M0.77,020 shs2,805 shsPJPInvesco Pharmaceuticals ETF$117.60-0.8%$112.04$80.63▼$122.69$353.98M0.4534,423 shs424,578 shsXPHSPDR S&P Pharmaceuticals ETF$66.82-2.4%$61.03$40.80▼$70.15$451.04M0.5887,164 shs111,836 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBHVanEck Biotech ETF-0.69%-2.94%+8.84%+5.31%+29.02%PBEInvesco Biotechnology & Genome ETF-0.67%-1.52%+7.68%+11.27%+36.92%PJPInvesco Pharmaceuticals ETF-0.80%-2.07%+3.29%+10.56%+42.58%XPHSPDR S&P Pharmaceuticals ETF-2.37%-0.68%+10.87%+16.68%+58.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBHVanEck Biotech ETF 2.68Moderate Buy$204.14N/APBEInvesco Biotechnology & Genome ETF 2.64Moderate Buy$90.56N/APJPInvesco Pharmaceuticals ETF 2.67Moderate Buy$117.60N/AXPHSPDR S&P Pharmaceuticals ETF 2.78Moderate Buy$66.82N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/APBEInvesco Biotechnology & Genome ETFN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/AN/APBEInvesco Biotechnology & Genome ETFN/AN/A20.44N/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/A15.59N/AN/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/A14.28N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBBHVanEck Biotech ETFN/AN/AN/AN/AN/APBEInvesco Biotechnology & Genome ETF$1.541.70%N/AN/AN/APJPInvesco Pharmaceuticals ETF$1.060.90%N/AN/AN/AXPHSPDR S&P Pharmaceuticals ETF$0.330.49%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBHVanEck Biotech ETF32.05%PBEInvesco Biotechnology & Genome ETFN/APJPInvesco Pharmaceuticals ETFN/AXPHSPDR S&P Pharmaceuticals ETFN/AInsider OwnershipCompanyInsider OwnershipBBHVanEck Biotech ETFN/APBEInvesco Biotechnology & Genome ETFN/APJPInvesco Pharmaceuticals ETFN/AXPHSPDR S&P Pharmaceuticals ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBHVanEck Biotech ETFN/A1.95 millionN/AOptionablePBEInvesco Biotechnology & Genome ETFN/A3.12 millionN/ANot OptionablePJPInvesco Pharmaceuticals ETFN/A3.01 millionN/ANot OptionableXPHSPDR S&P Pharmaceuticals ETFN/A6.75 millionN/ANot OptionablePJP, BBH, PBE, and XPH HeadlinesRecent News About These CompaniesWhich Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?July 8, 2026 | aol.comASPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0590June 22, 2026 | msn.comIs State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?June 5, 2026 | zacks.comUS FDA to review AI-based tool to predict drug-related liver damageJune 3, 2026 | reuters.comShould You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?June 3, 2026 | zacks.comDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?May 19, 2026 | 247wallst.comTrump to announce discount drug pricing expansion, White House official saysMay 18, 2026 | reuters.comIs State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?April 3, 2026 | zacks.comShould You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?March 30, 2026 | zacks.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0610March 23, 2026 | msn.comUS and China clash over fentanyl and tariffs at global drugs meetingMarch 9, 2026 | reuters.comThese 5 Undervalued ETFs Could Be Bargains Right NowFebruary 26, 2026 | 247wallst.comXPH’s 29% Run Looks Tempting, But The 5y Chart Is A WarningFebruary 18, 2026 | 247wallst.comXPH's 29% Run Looks Tempting, But The 5y Chart Is A WarningFebruary 18, 2026 | 247wallst.comIs State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?January 29, 2026 | zacks.comShould You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?January 28, 2026 | zacks.comXPH: Healthcare Dashboard For JanuaryJanuary 16, 2026 | seekingalpha.comState Street® SPDR® S&P® Pharmaceuticals ETFJanuary 11, 2026 | markets.businessinsider.com3 Undervalued ETFs to Buy Before 2026December 10, 2025 | zacks.comPharma ETF (XPH) Hits a New 52-Week HighDecember 9, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePJP, BBH, PBE, and XPH Company DescriptionsVanEck Biotech ETF NASDAQ:BBH$204.14 -1.41 (-0.69%) As of 07/13/2026 03:06 PM EasternThe BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Invesco Biotechnology & Genome ETF NYSEARCA:PBE$90.56 -0.61 (-0.67%) As of 07/13/2026 04:10 PM EasternPowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.Invesco Pharmaceuticals ETF NYSEARCA:PJP$117.60 -0.95 (-0.80%) As of 07/13/2026 04:10 PM EasternPowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH$66.82 -1.62 (-2.37%) As of 07/13/2026 04:10 PM EasternSPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
